Insiders · CABA

Mark Simon

Director at Cabaletta Bio, Inc. (CABA)

Mark Simon has filed 8 insider reports with the SEC since June 2022, as director at Cabaletta Bio, Inc. (CABA). In the last 12 months Mark Simon bought $25.3K of stock on the open market. The latest filing, on June 10, 2026, reports grant or award at Cabaletta Bio, Inc. (CABA).

Filings
8
Companies
1
Bought on market
$147K
Sold on market
None

Companies where Mark Simon is an insider

CompanyRoleShares heldBoughtSoldAvg buyPrice nowLast filing
Cabaletta Bio, Inc. logo
CABA
Cabaletta Bio, Inc.
Director147,205$147K$1.08$1.28+19%Jun 10, 2026

Shares held: common shares owned directly after the latest filing that states it. Avg buy: open-market purchase dollars divided by shares bought, every filing on record. Price now: the latest daily close, against the average buy price.

Every filing

Compare Mark Simon with

Other insiders at the same companies

Questions about Mark Simon

What is Mark Simon's role at Cabaletta Bio, Inc.?
Mark Simon reports to the SEC as director at Cabaletta Bio, Inc. (CABA), according to the latest filing on June 10, 2026.
How many shares does Mark Simon own?
After the latest filing that states it, Mark Simon directly owned 147,205 shares of Cabaletta Bio, Inc. (CABA). Shares held through trusts, funds or family members are reported separately and are not counted here.
Has Mark Simon bought or sold stock recently?
The most recent open-market purchase was on January 21, 2026: bought 11,061 shares of Cabaletta Bio, Inc. (CABA) for $25.3K at an average of $2.28.
How do I get alerts when Mark Simon files?
Follow Mark Simon on Quantisnow and you get an email, and a phone notification on Plus, within minutes of each new Form 4 or Form 5, and of each Form 144 notice of a planned sale.

From SEC Forms 3, 4, 5 and 144 filed by Mark Simon (SEC CIK 0001400717). Totals count each trade once, skipping amendments whose original is on file, from Jun 3, 2022 on. View on SEC EDGAR